This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
It now appears that we have a series of articles showing a suggested dose response related to the elevation of blood sugar in diabetic patients after being treated with ethacrynic acid. My colleague and I have shown that 100 mg of ethacrynic acid daily does not influence the carbohydrate metabolism of nondiabetic or diabetic individuals (Dis Chest51:282-287, 1967). Dige-Peterson has shown that a daily dose of 150 mg of ethacrynic acid does not alter carbohydrate metabolism. In an excellent article, Russell et al (JAMA205:81, 1968) have shown that the high maintenance dose of 200 mg daily alters the carbohydrate metabolism in diabetics when compared to a placebo medication but not to their control periods. The nondiabetogenic individuals did not show the above alteration. These studies certainly indicate that ethacrynic acid is a valuable and safe drug, even in the diabetic patient. They do
Diamond S. Ethacrynic Acid and Diabetes. JAMA. 1968;206(8):1793-1794. doi:10.1001/jama.1968.03150080073024